» Articles » PMID: 28883903

Dietary Polyphenols, Mediterranean Diet, Prediabetes, and Type 2 Diabetes: A Narrative Review of the Evidence

Overview
Publisher Wiley
Date 2017 Sep 9
PMID 28883903
Citations 113
Authors
Affiliations
Soon will be listed here.
Abstract

Dietary polyphenols come mainly from plant-based foods including fruits, vegetables, whole grains, coffee, tea, and nuts. Polyphenols may influence glycemia and type 2 diabetes (T2D) through different mechanisms, such as promoting the uptake of glucose in tissues, and therefore improving insulin sensitivity. This review aims to summarize the evidence from clinical trials and observational prospective studies linking dietary polyphenols to prediabetes and T2D, with a focus on polyphenol-rich foods characteristic of the Mediterranean diet. We aimed to describe the metabolic biomarkers related to polyphenol intake and genotype-polyphenol interactions modulating the effects on T2D. Intakes of polyphenols, especially flavan-3-ols, and their food sources have demonstrated beneficial effects on insulin resistance and other cardiometabolic risk factors. Several prospective studies have shown inverse associations between polyphenol intake and T2D. The Mediterranean diet and its key components, olive oil, nuts, and red wine, have been inversely associated with insulin resistance and T2D. To some extent, these associations may be attributed to the high amount of polyphenols and bioactive compounds in typical foods conforming this traditional dietary pattern. Few studies have suggested that genetic predisposition can modulate the relationship between polyphenols and T2D risk. In conclusion, the intake of polyphenols may be beneficial for both insulin resistance and T2D risk.

Citing Articles

Effects of Frozen Red Dragon Fruit Consumption on Metabolic Markers in Healthy Subjects and Individuals at Risk of Type 2 Diabetes.

Flores-Verastegui M, Coe S, Tammam J, Almahjoubi H, Bridle R, Bi S Nutrients. 2025; 17(3).

PMID: 39940297 PMC: 11821054. DOI: 10.3390/nu17030441.


Leaky Gut Syndrome: An Interplay Between Nutrients and Dysbiosis.

Marcari A, Paiva A, Simon C, Dos Santos M Curr Nutr Rep. 2025; 14(1):25.

PMID: 39890659 DOI: 10.1007/s13668-025-00614-7.


Protective Role of Dietary Polyphenols in the Management and Treatment of Type 2 Diabetes Mellitus.

Martiniakova M, Sarocka A, Penzes N, Biro R, Kovacova V, Mondockova V Nutrients. 2025; 17(2).

PMID: 39861406 PMC: 11767469. DOI: 10.3390/nu17020275.


Targeting the Gut Microbiota for Prevention and Management of Type 2 Diabetes.

Donati Zeppa S, Gervasi M, Bartolacci A, Ferrini F, Patti A, Sestili P Nutrients. 2024; 16(22).

PMID: 39599740 PMC: 11597803. DOI: 10.3390/nu16223951.


Dietary Polyphenols, Food Processing and Gut Microbiome: Recent Findings on Bioavailability, Bioactivity, and Gut Microbiome Interplay.

Sejbuk M, Mironczuk-Chodakowska I, Karav S, Witkowska A Antioxidants (Basel). 2024; 13(10).

PMID: 39456473 PMC: 11505337. DOI: 10.3390/antiox13101220.


References
1.
Kataja-Tuomola M, Kontto J, Mannisto S, Albanes D, Virtamo J . Intake of antioxidants and risk of type 2 diabetes in a cohort of male smokers. Eur J Clin Nutr. 2011; 65(5):590-7. DOI: 10.1038/ejcn.2010.283. View

2.
Corella D, Carrasco P, Sorli J, Estruch R, Rico-Sanz J, Martinez-Gonzalez M . Mediterranean diet reduces the adverse effect of the TCF7L2-rs7903146 polymorphism on cardiovascular risk factors and stroke incidence: a randomized controlled trial in a high-cardiovascular-risk population. Diabetes Care. 2013; 36(11):3803-11. PMC: 3816851. DOI: 10.2337/dc13-0955. View

3.
van der Made S, Plat J, Mensink R . Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial. PLoS One. 2015; 10(3):e0118393. PMC: 4366169. DOI: 10.1371/journal.pone.0118393. View

4.
McGuire S . Scientific Report of the 2015 Dietary Guidelines Advisory Committee. Washington, DC: US Departments of Agriculture and Health and Human Services, 2015. Adv Nutr. 2016; 7(1):202-4. PMC: 4717899. DOI: 10.3945/an.115.011684. View

5.
Palatini P, Benetti E, Mos L, Garavelli G, Mazzer A, Cozzio S . Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients. Eur J Epidemiol. 2015; 30(3):209-17. DOI: 10.1007/s10654-015-9990-z. View